PDS Biotechnology Corporation Profile Avatar - Palmy Investing

PDS Biotechnology Corporation

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment fo…

Biotechnology
US, Florham Park [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

PDS Biotechnology Corporation has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

PDS Biotechnology Corporation can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of PDS Biotechnology Corporation.

End of PDSB's Analysis
CIK: 1472091 CUSIP: 70465T107 ISIN: US70465T1079 LEI: - UEI: -
Secondary Listings
PDSB has no secondary listings inside our databases.